ストックスクリーナーアプリを入手
4.5862
0.96%
0.0462
前日終値:
$4.54
開ける：
$4.55
24時間の取引高:
212.02K
Relative Volume:
0.21
時価総額：
$878.94M
収益：
$12.99M
当期純損益:
$-74.39M
株価収益率:
-10.42
EPS:
-0.44
ネットキャッシュフロー:
$-78.92M
1週間 パフォーマンス:
+2.08%
1か月 パフォーマンス:
+23.54%
6か月 パフォーマンス:
+31.71%
1年 パフォーマンス:
+19.67%
1日の値動き範囲:
$4.54
$4.6599
1週間の範囲:
$4.25
$4.6599
52週間の値動き範囲:
$2.705
$5.10
Arbutus Biopharma Corp Stock (ABUS) Company Profile
名前
Arbutus Biopharma Corp
セクター
電話
604-419-3200
住所
701 VETERANS CIRCLE, WARMINSTER, PA
ABUS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ABUS
Arbutus Biopharma Corp
|
4.585 | 870.31M | 12.99M | -74.39M | -78.92M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.21 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.84 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
459.38 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
768.65 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
343.93 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Arbutus Biopharma Corp Stock (ABUS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-02-02 | アップグレード | Jefferies | Hold → Buy |
| 2021-02-25 | 開始されました | Jefferies | Hold |
| 2020-12-17 | 開始されました | H.C. Wainwright | Buy |
| 2020-07-27 | 再開されました | JMP Securities | Mkt Outperform |
| 2020-07-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-05-19 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-03-06 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2020-02-20 | 開始されました | Robert W. Baird | Outperform |
| 2020-02-05 | アップグレード | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-10-07 | 繰り返されました | B. Riley FBR | Buy |
| 2019-10-04 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2018-10-16 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2018-10-15 | アップグレード | Wedbush | Underperform → Neutral |
| 2018-10-12 | 繰り返されました | Chardan Capital Markets | Buy |
| 2018-07-06 | ダウングレード | B. Riley FBR, Inc. | Buy → Neutral |
| 2018-03-19 | 再開されました | Chardan Capital Markets | Buy |
| 2018-03-19 | ダウングレード | Wedbush | Outperform → Neutral |
| 2018-01-05 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-04-04 | アップグレード | Chardan Capital Markets | Neutral → Buy |
| 2017-02-01 | 繰り返されました | Wedbush | Outperform |
| 2016-12-13 | ダウングレード | Chardan Capital Markets | Buy → Neutral |
| 2016-11-30 | アップグレード | Chardan Capital Markets | Neutral → Buy |
すべてを表示
Arbutus Biopharma Corp (ABUS) 最新ニュース
Risk vs reward if holding onto Arbutus Biopharma CorporationPortfolio Value Report & Verified Chart Pattern Signals - newser.com
Will Arbutus Biopharma Corporation stock deliver better than expected guidanceShort Setup & Long Hold Capital Preservation Plans - newser.com
Arbutus Biopharma's CFO David Hastings sells shares worth $72,826 - MSN
Has Arbutus Biopharma Corporation formed a bullish divergenceWeekly Trend Summary & Fast Gaining Stock Strategy Reports - newser.com
Is Arbutus Biopharma Corporation stock a buy on dipsGold Moves & High Accuracy Investment Signals - newser.com
Assenagon Asset Management S.A. Makes New $122,000 Investment in Arbutus Biopharma Corporation $ABUS - Defense World
Applying Wyckoff theory to Arbutus Biopharma Corporation stockEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Is Arbutus Biopharma Corporation reversing from oversold territoryJuly 2025 WrapUp & Fast Gain Stock Tips - newser.com
Arbutus Biopharma Corporation Stock Analysis and ForecastEarnings Miss Alerts & Easy Tools to Analyze Your Investment Risk - earlytimes.in
Is Arbutus Biopharma Corporation forming a reversal pattern2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
Does Arbutus Biopharma Corporation fit your quant trading modelJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Statistical indicators supporting Arbutus Biopharma Corporation’s strengthWeekly Risk Summary & Precise Swing Trade Alerts - newser.com
Can machine learning forecast Arbutus Biopharma Corporation recoveryJuly 2025 Momentum & Expert Curated Trade Setup Alerts - newser.com
Building trade automation scripts for Arbutus Biopharma Corporation2025 Price Momentum & Verified Trade Idea Suggestions - newser.com
What MACD signals say about Arbutus Biopharma Corporation2025 Historical Comparison & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of Arbutus Biopharma Corporation with statistical tools2025 Technical Patterns & Expert Approved Momentum Ideas - newser.com
What machine learning models say about Arbutus Biopharma Corporation2025 Key Lessons & AI Based Buy/Sell Signal Reports - newser.com
Arbutus Biopharma Corporation stock volume spike explainedQuarterly Risk Review & High Win Rate Trade Alerts - newser.com
Is Arbutus Biopharma Corporation stock bottoming outLong Setup & Weekly Setup with ROI Potential - newser.com
what machine learning models say about arbutus biopharma corporationJuly 2025 PreEarnings & Risk Controlled Daily Plans - newser.com
Using economic indicators to assess Arbutus Biopharma Corporation potential2025 Market WrapUp & Stepwise Trade Signal Guides - newser.com
Aug Setups: Whats next for Arbutus Biopharma Corporation stockLong Setup & Weekly Breakout Watchlists - خودرو بانک
Reversal indicators forming on Arbutus Biopharma Corporation stockQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Arbutus Biopharma Corporation $ABUS Shares Purchased by Goldman Sachs Group Inc. - MarketBeat
Aug Rallies: Is Arbutus Biopharma Corporation stock a top performer YTD2025 Price Action Summary & Technical Pattern Based Signals - خودرو بانک
RSI Check: Should I set a stop loss on RELYMarket Performance Report & Free Community Consensus Stock Picks - خودرو بانک
Arbutus: IP Drama With High Stakes (NASDAQ:ABUS) - Seeking Alpha
Fundamentals Check: What’s next for Arbutus Biopharma Corporation stockWeekly Volume Report & Risk Controlled Daily Trade Plans - خودرو بانک
Published on: 2025-09-15 00:38:22 - newser.com
is arbutus biopharma corporation reversing from oversold territory2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 4.6%What's Next? - MarketBeat
Arbutus Biopharma Corporation stock retracement – recovery analysisQuarterly Growth Report & Expert Approved Momentum Ideas - newser.com
Arbutus Biopharma Corp (ABUS) 財務データ
収益
当期純利益
現金流量
EPS
1.62%
大文字化:
|
ボリューム (24 時間):